New blood test flags aggressive thyroid cancers before surgery

Researchers have developed a simple DNA screening method that identifies high-risk thyroid cancers during routine needle biopsies, potentially sparing thousands of patients from unnecessary surgery. The test detects a specific genetic mutation and could reshape how clinicians triage thyroid lesions, reducing both healthcare costs and patient anxiety.

Originaltitel: Digital droplet PCR <i>TERT</i> promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre-operative identification of high-risk cases